SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001477932-23-002970
Filing Date
2023-04-28
Accepted
2023-04-28 16:06:40
Documents
13
Period of Report
2023-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A vnrx_def14a.htm DEF 14A 732337
2 vnrx_def14aimg28.jpg GRAPHIC 31248
3 vnrx_def14aimg27.jpg GRAPHIC 28075
4 vnrx_def14aimg26.jpg GRAPHIC 132587
5 vnrx_def14aimg25.jpg GRAPHIC 169372
6 vnrx_def14aimg24.jpg GRAPHIC 186530
7 vnrx_def14aimg23.jpg GRAPHIC 149736
8 vnrx_def14aimg22.jpg GRAPHIC 3652
9 vnrx_def14aimg20.jpg GRAPHIC 3675
10 vnrx_def14aimg19.jpg GRAPHIC 23998
11 vnrx_def14aimg16.jpg GRAPHIC 4492
12 vnrx_def14aimg15.jpg GRAPHIC 4385
13 vnrx_def14aimg14.jpg GRAPHIC 4798
  Complete submission text file 0001477932-23-002970.txt   1757542
Mailing Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014
Business Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36833 | Film No.: 23865962
SIC: 2835 In Vitro & In Vivo Diagnostic Substances